glp-1 drugs and parkinson's disease Are we measuring the wrong primary outcome for for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep Can one drug do it
Pay in 4 interest-free payments of $6.20 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10




















01585-5/asset/19c5e1a6-3ebc-453e-87c3-a11a7b2d6a64/main.assets/gr1.gif)





